Assessment of sigma-1 receptor occupancy in mice with non-radiolabelled FTC-146 as a tracer

References

• Bolshakova AV, Kukanova EO, Gainullina AN, et al. Sigma-1 receptor as a potential pharmacological target for the treatment of neuropathology. St. Petersburg Polytech Univ J.: Phys Math. 2016;2:31–40.
   Google Scholar
• Hayashi T, Stahl SM. The sigma-1 (σ1) receptor and its role in the treatment of mood disorders. Drugs Fut. 2009;34:137–146.
   Web of Science ®Google Scholar
• Su TP, Hayashi T, Maurice T, et al. The sigma-1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol Sci. 2010;31:557–566.
   PubMed Web of Science ®Google Scholar
• Matsumoto RR, Bowen WD, Su TP. Sigma receptors: chemistry, cell biology and clinical implications. New York: Springer; 2007.
   Google Scholar
• Cobos EJ, Entrena JM, Nieto FR, et al. Pharmacology and therapeutic potential of sigma(1) receptor ligands. Curr Neuropharmacol. 2008;6:344–366.
   PubMed Web of Science ®Google Scholar
• Alonso G, Phan V, Guillemain I, et al. Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system. Neuroscience. 2000;97:155–170.
   PubMed Web of Science ®Google Scholar
• Toyohara J, Sakata M, Ishiwata K. Imaging of sigma1 receptors in the human brain using pet and [11C] SA4503. Cent Nerv Syst Agents Med Chem. 2009;9:190–196.
   PubMedGoogle Scholar
• Waterhouse RN, Collier TL. In vivo evaluation of [F-18]1-(3-fluoropropyl)-4-(4-cyanophenoxymethyl)piperidine: a selective sigma-1 receptor radioligand for PET. Nucl Med Biol. 1997;24:127–134.
   PubMed Web of Science ®Google Scholar
• Stone JM, Arstad E, Erlandsson K, et al. [123I]TPCNE–a novel SPET tracer for the sigma-1 receptor: first human studies and in vivo haloperidol challenge. Synapse. 2006;60(2):109–117.
   PubMed Web of Science ®Google Scholar
• Shen B, James LM, Andrews L, et al. Further validation to support clinical translation of [18F]FTC-146 for imaging sigma-1 receptors. EJNMMI Res. 2015;5:49.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang X, Zhang J, et al. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising sigma1 receptor imaging agent. Bioorg Med Chem. 2014;22: 5270–5278.
   PubMed Web of Science ®Google Scholar
• Barth VN, Chernet E, Martin LJ, et al. Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer. Life Sci. 2006;78: 3007–3012.
   PubMed Web of Science ®Google Scholar
• Frieboes RM, Murck H, Antonijevic I, et al. Characterization of the sigma ligand panamesine, a potential antipsychotic, by immune response in patients with schizophrenia and by sleep-EEG changes in normal controls. Psychopharmacology. 1999;141:107–110.
   PubMed Web of Science ®Google Scholar
• Friedman JR, Lackner LL, West M, et al. ER tubules mark sites of mitochondrial division. Science. 2011;334:358–362.
   PubMed Web of Science ®Google Scholar
• Bermack JE, Debonnel G. Modulation of serotonergic neurotransmission by short- and long-term treatments with sigma ligands. Br J Pharmacol. 2001;134:691–699.
   PubMed Web of Science ®Google Scholar
• Rogóz Z, Skuza G. Mechanism of synergistic action following co-treatment with pramipexole and fluoxetine or sertraline in the forced swimming test in rats. Pharmacol Rep. 2006;58:493–500.
   PubMed Web of Science ®Google Scholar
• Dhir A, Kulkarni SK. Involvement of sigma-1 receptor modulation in the antidepressant action of venlafaxine. Neurosci Lett. 2007;420:204–208.
   PubMed Web of Science ®Google Scholar
• Maurice T, Su TP. The pharmacology of sigma-1 receptors. Pharmacol Ther. 2009;124:195–206.
   PubMed Web of Science ®Google Scholar
• Jansen KL, Faull RL, Storey P, et al. Loss of sigma binding sites in the CA1 area of the anterior hippocampus in Alzheimer’s disease correlates with CA1 pyramidal cell loss. Brain Res. 1993;623:299–302.
   PubMed Web of Science ®Google Scholar
• Maurice T, Lockhart BP. Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:69–102.
   PubMed Web of Science ®Google Scholar
• Maurice T, Gregoire C, Espallergues J. Neuro(active) steroids actions at the neuromodulatory sigma1 (sigma1) receptor: biochemical and physiological evidences, consequences in neuroprotection. Pharmacol Biochem Behav. 2006;84:581–597.
   PubMed Web of Science ®Google Scholar
• Francardo V, Bez F, Wieloch T, et al. Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental Parkinsonism. Brain. 2014;137:1998.
   PubMed Web of Science ®Google Scholar
• Mishina M, Ishiwata K, Ishii K, et al. Function of sigma1 receptors in Parkinson's disease. Acta Neurol Scand. 2005;112:103–107.
   PubMed Web of Science ®Google Scholar
• James ML, Shen B, Nielsen CH, et al. Evaluation of σ-1 receptor radioligand 18F-FTC-146 in rats and squirrel monkeys using PET. J Nucl Med. 2014;55:147–153.
   PubMed Web of Science ®Google Scholar
• Jesudason CD, DuBois S, Johnson M, et al. In vivo receptor occupancy in rodents by LC-MS/MS. In: Sittampalam GS, Coussens NP, Brimacombe K, et al., editors. Assay guidance manual. Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2017.
   Google Scholar
• Ishiwata K, Kawamura K, Kobayashi T, et al. Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands. Nucl Med Biol. 2003;30:429–434.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan NK, Schepers M, Luurtsema G, et al. Cutamesine overcomes REM sleep deprivation-induced memory loss: relationship to sigma-1 receptor occupancy. Mol Imaging Biol. 2015;17:364–372.
   PubMed Web of Science ®Google Scholar
• Ishikawa M, Sakata M, Ishii K, et al. High occupancy of sigma1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503. Int J Neuropsychopharmacol. 2009;12(8):1127–1131.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan NK, Visser AK, Schepers M, et al. Dose-dependent sigma-1 receptor occupancy by donepezil in rat brain can be assessed with (11)C-SA4503 and microPET. Psychopharmacology. 2014;231:3997–4006.
   PubMed Web of Science ®Google Scholar
• Kunitachi S, Fujita Y, Ishima T, et al. Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors. Brain Res. 2009;1279:189–196.
   PubMed Web of Science ®Google Scholar
• James ML, Shen B, Zavaleta CL, et al. New positron emission tomography (PET) radioligand for imaging σ-1 receptors in living subjects. J Med Chem. 2012;55:8272–8282.
   PubMed Web of Science ®Google Scholar
• Chen Y-Y, Wang X, Zhang J-M, et al. Synthesis and evaluation of a 18F-labeled spirocyclic piperidine derivative as promising sigma1 receptor imaging agent. Bioorganic Med Chem. 2014;22:5270–5278.
   Google Scholar
• Hashirnoto K, London ED. Interactions of erythro-ifenprodil, threo-ifenprodil, erythro-iodoifenprodil, and eliprodil with subtypes of σ receptors. Eur J Pharmacol. 1995;273:307–310.
   PubMed Web of Science ®Google Scholar